Evidence map›Paper›PMID 40351118›Full record

ArticleOncoimmunology2025

CD8

Carolina Abrate, Fernando P Canale, Sabrina N Bossio, Jimena Tosello Boari, María C Ramello, Nicolas Nuñez, Wilfrid Richer, Christine Sedlik, Jordan Denizeau, Anne Vincent-Salomon and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncoimmunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Terminally exhausted CD8Frontiers in immunology · 2025
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Carolina AbrateDepartamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina.
Fernando P CanaleInflammation Research Lab, Institute of Experimental Immunology, University of Zürich, Zürich, Switzerland.
Sabrina N BossioDepartamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina.
Jimena Tosello BoariINSERM U932 Immunity and Cancer, Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France.
María C RamelloDepartamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina.
Nicolas NuñezINSERM U932 Immunity and Cancer, Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France.
Wilfrid RicherINSERM U932 Immunity and Cancer, Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France.
Christine SedlikINSERM U932 Immunity and Cancer, Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France.
Jordan DenizeauINSERM U932 Immunity and Cancer, Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France.
Anne Vincent-SalomonDiagnostic and Theranostic Medicine Division, Institut Curie, PSL Research University, Paris, France.
Edith BorcomanINSERM U932 Immunity and Cancer, Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France.
Andres Del CastilloDepartamento de Mastología y Ginecología - Hospital Rawson, Polo Hospitalario, Córdoba, Argentina.
Adriana GruppiDepartamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina.
Eva V Acosta RodríguezDepartamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina.
Eliane PiaggioINSERM U932 Immunity and Cancer, Department of Translational Research, PSL Research University, Institut Curie Research Center, Paris, France.
Carolina L MontesDepartamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina.ORCID 0000-0003-0494-1820

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CD8

Indexed as

Breast NeoplasmsCD8-Positive T-LymphocytesLymph NodesLymphocytes, Tumor-InfiltratingProgrammed Cell Death 1 ReceptorFemaleHumansPrognosisPDCD1 protein, humanProgrammed Cell Death 1 ReceptorBreast cancerCD8+ T cellsdraining lymph nodesexhaustionPD-1

Identifiers

PMID40351118
PMCPMC12077459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.